← Back to Screener
Revvity, Inc. (RVTY)
Price$93.03
Favorite Metrics
Price vs S&P 500 (26W)-2.33%
Price vs S&P 500 (4W)-0.16%
Market Capitalization$10.39B
P/E Ratio (Annual)43.06x
Indicated Dividend Yield (Annual)0.30%
All Metrics
P/CF (Annual)17.82x
Book Value / Share (Quarterly)$64.57
P/TBV (Annual)2.25x
Indicated Dividend (Annual)$0.28
Revenue Growth (3Y)-4.82%
Cash Flow / Share (Quarterly)$4.54
Payout Ratio (TTM)13.60%
Price vs S&P 500 (YTD)-7.02%
Gross Margin (TTM)54.77%
Net Profit Margin (TTM)8.45%
EPS (TTM)$2.08
10-Day Avg Trading Volume0.82M
EPS Excl Extra (TTM)$2.08
Revenue Growth (5Y)-5.46%
EPS (Annual)$2.07
Dividend / Share (Annual)$0.28
ROI (Annual)2.30%
Gross Margin (Annual)54.77%
Net Profit Margin (5Y Avg)17.06%
Cash / Share (Quarterly)$8.19
P/E Basic Excl Extra (TTM)43.06x
Revenue Growth QoQ (YoY)5.85%
EPS Growth (5Y)-20.45%
P/E Normalized (Annual)43.06x
ROA (Last FY)1.98%
Revenue Growth TTM (YoY)3.67%
EBITD / Share (TTM)$6.53
ROE (5Y Avg)7.32%
Operating Margin (TTM)12.49%
Cash Flow / Share (Annual)$4.54
P/B Ratio1.43x
P/B Ratio (Quarterly)1.52x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)4.44x
Net Interest Coverage (TTM)4.07x
ROA (TTM)1.97%
EPS Growth QoQ (YoY)11.51%
EV / EBITDA (TTM)16.67x
EPS Incl Extra (Annual)$2.07
Current Ratio (Annual)1.68x
Quick Ratio (Quarterly)1.40x
3-Month Avg Trading Volume1.24M
52-Week Price Return0.22%
EV / Free Cash Flow (Annual)24.90x
P/E Incl Extra (TTM)43.06x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$43.67
P/S Ratio (Annual)3.64x
Asset Turnover (Annual)0.23x
52-Week High$118.30
Operating Margin (5Y Avg)18.26%
EPS Excl Extra (Annual)$2.07
CapEx CAGR (5Y)-1.05%
26-Week Price Return6.42%
Quick Ratio (Annual)1.40x
13-Week Price Return-15.75%
Total Debt / Equity (Annual)0.44x
Current Ratio (Quarterly)1.68x
Enterprise Value$12,686.733
Revenue / Share Growth (5Y)-6.21%
Asset Turnover (TTM)0.23x
Book Value / Share Growth (5Y)20.85%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)3.46x
Pretax Margin (Annual)9.39%
Cash / Share (Annual)$8.19
3-Month Return Std Dev38.40%
Gross Margin (5Y Avg)58.05%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-8.80%
EBITDA Interim CAGR (5Y)-10.21%
ROE (Last FY)3.33%
Net Interest Coverage (Annual)4.07x
EPS Basic Excl Extra (Annual)$2.07
P/FCF (TTM)20.39x
Receivables Turnover (TTM)4.15x
EV / Free Cash Flow (TTM)24.90x
Total Debt / Equity (Quarterly)0.44x
EPS Incl Extra (TTM)$2.08
Receivables Turnover (Annual)4.15x
ROI (TTM)2.26%
Dividend Growth Rate (5Y)0.08%
P/S Ratio (TTM)3.64x
Pretax Margin (5Y Avg)15.73%
Revenue / Share (Annual)$24.50
Tangible BV / Share (Annual)$43.67
Forward P/E17.25x
Free OCF CAGR (5Y)-8.96%
Price vs S&P 500 (52W)-34.87%
P/E Ratio (TTM)43.06x
EPS Growth TTM (YoY)-5.53%
Year-to-Date Return-2.88%
5-Day Price Return1.42%
EPS Normalized (Annual)$2.07
ROA (5Y Avg)3.92%
Net Profit Margin (Annual)8.45%
Month-to-Date Return7.25%
Cash Flow / Share (TTM)$5.13
EBITD / Share (Annual)$6.53
EPS Growth (3Y)-22.83%
Operating Margin (Annual)12.49%
LT Debt / Equity (Annual)0.36x
P/CF (TTM)17.82x
ROI (5Y Avg)4.66%
P/E Excl Extra (TTM)43.06x
LT Debt / Equity (Quarterly)0.36x
EPS Basic Excl Extra (TTM)$2.08
P/TBV (Quarterly)2.25x
Payout Ratio (Annual)13.60%
P/B Ratio (Annual)1.52x
Dividend / Share (TTM)$0.28
Inventory Turnover (TTM)3.46x
Pretax Margin (TTM)9.39%
Book Value / Share (Annual)$64.57
Price vs S&P 500 (13W)-18.61%
Net Margin Growth (5Y)-15.17%
Dividend Yield (TTM)0.32%
Beta1.14x
P/FCF (Annual)20.39x
Revenue / Share (TTM)$25.24
ROE (TTM)3.24%
52-Week Low$81.36
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.73
3.73
3.73
3.77
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $93.03 |
AAgilent Technologies Inc. | 4.83x | 5.41% | 52.60% | 20.40% | $120.96 |
WATWaters Corp | 10.18x | 6.00% | 59.28% | 25.36% | $335.61 |
MTDMettler-Toledo International | 6.66x | 5.47% | 59.37% | 26.05% | $1324.66 |
ILMNIllumina Inc | 4.69x | 6.04% | 66.61% | 18.44% | $132.86 |
BIOBio-Rad Laboratories, Inc.Class A | 3.17x | 0.29% | 52.01% | 1.59% | $303.34 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.17x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRBruker Corporation | 1.81x | 11.57% | 47.13% | 1.40% | $41.10 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.81x | 11.57% | 47.13% | 1.40% | $320.13 |
AVTRAvantor, Inc. | 0.88x | 0.49% | 32.65% | -3.83% | $8.50 |
TXG10x Genomics, Inc. Class A Common Stock | 5.18x | 16.56% | 69.13% | -9.49% | $24.59 |
About
Revvity, formed in 2023 through PerkinElmer's rebranding, is a global life sciences and diagnostics company serving biopharma, academic research, and clinical markets. The company operates two segments: Life Sciences, providing reagents and instruments for research applications, and Diagnostics, delivering immunodiagnostics and newborn and reproductive health solutions. With established operations across North America, Europe, and China, Revvity serves customers worldwide in research and clinical diagnostics.